Collectively, these findings suggest that dormant tumor cells that survive HER2/neu or Wnt1 downregulation exhibit gene expression profiles resembling those of normal mammary stem cells and tumorigenic breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.